Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on DHT Holdings (DHT – Research Report), EasyJet (EJTTF – Research Report) and AZEK Company (AZEK – Research Report).
DHT Holdings (DHT)
Jefferies analyst Omar Nokta maintained a Buy rating on DHT Holdings today and set a price target of $12.00. The company’s shares closed last Monday at $9.72, close to its 52-week high of $10.64.
According to TipRanks.com, Nokta is a 5-star analyst with an average return of
Currently, the analyst consensus on DHT Holdings is a Strong Buy with an average price target of $11.40, which is a 12.9% upside from current levels. In a report issued on November 23, Kepler Capital also maintained a Buy rating on the stock with a $12.40 price target.
See today’s best-performing stocks on TipRanks >>
EasyJet (EJTTF)
J.P. Morgan analyst Harry Gowers maintained a Sell rating on EasyJet today and set a price target of £2.60. The company’s shares closed last Wednesday at $4.53.
According to TipRanks.com, Gowers is ranked #5997 out of 8141 analysts.
The word on The Street in general, suggests a Hold analyst consensus rating for EasyJet with a $5.69 average price target.
AZEK Company (AZEK)
RBC Capital analyst Michael Dahl maintained a Buy rating on AZEK Company today and set a price target of $20.00. The company’s shares closed last Monday at $17.41, close to its 52-week low of $15.12.
According to TipRanks.com, Dahl is a 4-star analyst with an average return of
Currently, the analyst consensus on AZEK Company is a Strong Buy with an average price target of $22.11, implying a 21.9% upside from current levels. In a report issued on November 23, UBS also maintained a Buy rating on the stock with a $26.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on DHT:
- Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR) and Axsome Therapeutics (AXSM)
- Adyton Resources Announces Filing of Financial Statements and MD&A for the three and nine months ended September 30, 2022
- Baidu Unveils Plan to Build World’s Largest Ride-Hailing Service Area
- Stock Market Today: Futures Up As China Reassures of Effective COVID-Control
- Lithia & Driveway (LAD) Expands in Texas, Adding over $200 Million in Annualized Revenue
